H19 and embryonal carcinoma: However, the proliferation ability of H19 knockdown iPSCs was consistent with Zeira’s results regarding inhibited H19 reducing the proliferation of human embryonic carcinoma cells (hECs) and embryonic stem (hES) cells [18].